期刊文献+

受控衰减参数诊断脂肪肝的临界值初探:一项多中心临床研究 被引量:17

A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver
原文传递
导出
摘要 目的 评价受控衰减参数(CAP)鉴别5%以上肝脂肪变的临界值及影响因素. 方法 纳入5个中心经“肝活体组织检查”证实的成年(>18岁)非酒精性脂肪性肝病(NAFLD)及慢性乙型肝炎(CHB)患者332例,按病理学标准将肝脂肪含量分为S0(<5%)、S1(≥5%)二个等级.使用FibroScan-502机型及M型探头完成CAP值测定.绘制CAP鉴别5%以上肝脂肪变的受试者工作特征曲线(ROC)及计算曲线下面积(AUROC),采用最大Youden指数判定最佳临界值,并计算此值时的灵敏度及特异度等. 结果 332例患者中NAFLD组67例,年龄中位数及四分位间距(IQR)为39.0 (32.0 ~ 50.5),CHB组同样年龄中位数及IQR为37.0 (28.0 ~ 45.0),男性46例;CHB组共265例,年龄IQR为(28.0 ~ 45.0)岁,中位数为37.0岁,男性182例,两组间年龄、性别差异无统计学意义.多元线性回归分析提示,体质量指数(BMI)及肝脂肪变程度与CAP呈独立正相关.CAP在S0组IQR为(190.0 ~ 241.0) dB/m,中位数为215.0 dB/m,S1组IQR为(255.0 ~ 325.5) dB/m,中位数为294.0 dB/m,S1组显著高于S0组,P< 0.01.BMI<25(kg/m2)时,CAP诊断5%脂肪变的AUROC为0.853,最佳临界值为244.5(dB/m);BMI≥25(kg/m2)时,CAP诊断5%脂肪变的AUROC为0.835,最佳临界值为269.5 dB/m. 结论 CAP可以鉴别5%以上肝脂肪变,适用于脂肪肝的无创诊断,但需要对BMI进行校正. Objective To evaluate the controlled attenuation parameter (CAP) assessment of fatty liver and choose a cut-off value of hepatic steatosis more than 5%.Methods Consecutive patients,18 years or older,who had undergone percutaneous liver biopsy and CAP measurement were recruited from five liver healthcare centers in China.All enrollees were categorized as hepatic steatosis grade S0 (〈5%) or S1 (≥5%).An M-probe equipped FibroScan 502 was used to capture CAP values.Receiver operating characteristic (ROC) curves were plotted,and the areas under (AU) the curves were calculated to determine the diagnostic efficacy.The CAP cut-offvalues at the optimal thresholds were defined by maximum Youden indices; sensitivity and specificity were also calculated.Results A total of 332 patients were enrolled in the study,tcluding 67 patients with non-alcoholic fatty liver disease (NAFLD) and 265 with chronic hepatitis B (CHB) viru:infection.The median age (inter quartile range,IQR) of the study cohort was 39.0 (32.0-50.5) years-old.There were 46 males (68.7%) in the NAFLD group,with a median age of 37.0 (28.0-45.0) years-old,and 182 males (68.7%) in the CHB group; the differences between the two groups in median age and male:female ratio did not reach statistical significance.Multivariate linear regression analysis identified steatosis grade and body mass index (BMI) as independently associated with CAP.The median (IQR) CAP values among patients with S0 and S1 grade steatosis were 215.0 (190.0-241.0) dB/m and 294.0 (255.0-325.5) dB/m (P 〈 0.001),respectively.For all patients,when BMIwas 〈25 kg/rn2,the ability of the AUROC of the CAP to discriminate hepatic steatosis ≥5% was 0.853,and the optimal cut-off value was 244.5 dB/m; however,when BMI ≥25 kg/m2,the AUROC was 0.835 and the optimal cut-off value 269.5 dB/m.Conclusion CAP can identify hepatic steatosis ≥5% and is applicable for the diagnosis of fatty liver if it is adjusted for BMI.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2014年第12期926-931,共6页 Chinese Journal of Hepatology
基金 国家重点基础研究发展计划项目(2012CB517501) 中国肝炎防治基金会王宝恩肝纤维化研究基金(XJS20120501)
关键词 慢性肝炎 乙型 脂肪肝 诊断 瞬时弹性成像 受控衰减参数 Hepatitis B,chronic Fatty liver Diagnosis Transient elastography Controlled attenuation parameter
  • 相关文献

参考文献2

二级参考文献13

  • 1Beom Kyung Kim,James Fung,Man-Fung Yuen,Seung Up Kim.Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives[J].World Journal of Gastroenterology,2013,19(12):1890-1900. 被引量:15
  • 2Martin Blachier,Henri Leleu,Markus Peck-Radosavljevic,Dominique-Charles Valla,Fran?oise Roudot-Thoraval.The burden of liver disease in Europe: A review of available epidemiological data[J].Journal of Hepatology.2013(3)
  • 3Robert P. Myers,Aaron Pollett,Richard Kirsch,Gilles Pomier‐Layrargues,Melanie Beaton,Mark Levstik,Andres Duarte‐Rojo,David Wong,Pam Crotty,Magdy Elkashab.Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography[J].Liver Int.2012(6)
  • 4Manoj Kumar,Archana Rastogi,Tarandeep Singh,Chhagan Behari,Ekta Gupta,Hitendra Garg,Ramesh Kumar,Vikram Bhatia,Shiv K Sarin.Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance?[J].J Gastroenterol Hepatol.2013(7)
  • 5Vincent Wai-Sun Wong,Grace Lai-Hung Wong,Winnie Chiu-Wing Chu,Angel Mei-Ling Chim,Arlinking Ong,David Ka-Wai Yeung,Karen Kar-Lum Yiu,Shirley Ho-Ting Chu,Hoi-Yun Chan,Jean Woo,Francis Ka-Leung Chan,Henry Lik-Yuen Chan.Hepatitis B virus infection and fatty liver in the general population[J].Journal of Hepatology.2011(3)
  • 6M. Sasso,V. Miette,L. Sandrin,M. Beaugrand.The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan ?[J].Clinics and Research in Hepatology and Gastroenterology.2011(1)
  • 7Tomoko Hatta,Yasunari Fujinaga,Masumi Kadoya,Hitoshi Ueda,Hiroaki Murayama,Masahiro Kurozumi,Kazuhiko Ueda,Michiharu Komatsu,Tadanobu Nagaya,Satoru Joshita,Ryo Kodama,Eiji Tanaka,Tsuyoshi Uehara,Kenji Sano,Naoki Tanaka.Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease[J].Journal of Gastroenterology.2010(12)
  • 8Magali Sasso,Michel Beaugrand,Victor de Ledinghen,Catherine Douvin,Patrick Marcellin,Raoul Poupon,Laurent Sandrin,Véronique Miette.Controlled Attenuation Parameter (CAP): A Novel VCTE? Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes[J].Ultrasound in Medicine & Biology.2010(11)
  • 9Silvia Gaia,Silvia Carenzi,Angela L. Barilli,Elisabetta Bugianesi,Antonina Smedile,Franco Brunello,Alfredo Marzano,Mario Rizzetto.Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis[J].Journal of Hepatology.2010
  • 10Sang Hoon Ahn,Henry L. Y. Chan,Pei-Jer Chen,Jun Cheng,Mahesh K. Goenka,Jinlin Hou,Seng Gee Lim,Masao Omata,Teerha Piratvisuth,Qing Xie,Hyung Joon Yim,Man-Fung Yuen.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions[J].Hepatology International.2010(1)

共引文献92

同被引文献132

引证文献17

二级引证文献453

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部